A Phase II Clinical and Translational Study of MK-2206 in Patients with Metastatic Neuroendocrine Tumors (NETs)

被引：0
作者：
Reidy-Lagunes, Diane [1 ,2 ]
Pietanza, M. Catherine [1 ,2 ]
Sega, Michal [1 ,2 ]
Capanu, Marinela [1 ,2 ]
Saltz, Leonard [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
来源：
PANCREAS | 2014年 / 43卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [41] Phase II Study of an AKT Inhibitor MK2206 in Patients with Relapsed or Refractory Lymphoma
    Oki, Yasuhiro
    Fanale, Michelle A.
    Romaguera, Jorge E.
    Fayad, Luis
    Fowler, Nathan
    Copeland, Amanda R. M.
    Samaniego, Felipe
    Kwak, Larry W.
    Neelapu, Sattva S.
    Wang, Michael
    Feng, Lei
    Younes, Anas
    BLOOD, 2014, 124 (21)
  • [42] A Phase I Study of the Potent AKT Inhibitor MK-2206 in Combination With Carboplatin and Paclitaxel, Docetaxel or Erlotinib in Patients With Advanced Solid Tumours
    Molife, L. R.
    Minton, S.
    Vitfell-Pedersen, J.
    Chen, E.
    Sullivan, D.
    Yan, L.
    Zernhelt, A. M.
    Siu, L.
    de Bono, J. S.
    Tolcher, A. W.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S144 - S145
  • [43] Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma
    Oki, Yasuhiro
    Fanale, Michelle
    Romaguera, Jorge
    Fayad, Luis
    Fowler, Nathan
    Copeland, Amanda
    Samaniego, Felipe
    Kwak, Larry W.
    Neelapu, Sattva
    Wang, Michael
    Feng, Lei
    Younes, Anas
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) : 463 - 470
  • [44] A phase II trial of atezolizumab and bevacizumab in patients with advanced, progressive neuroendocrine tumors (NETs)
    Halperin, Daniel M.
    Liu, Suyu
    Dasari, Arvind
    Fogelman, David R.
    Bhosale, Priya
    Mahvash, Armeen
    Dervin, Shannon
    Estrella, Jeannelyn
    Cortazar, Patricia
    Maru, Dipen M.
    Mckenna, Edward Francis
    Wistuba, Ignacio Ivan
    Schulze, Katja
    Futreal, Phillip Andrew
    Darbonne, Walter C.
    Yun, Cindy
    Hwu, Patrick
    Yao, James C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [45] Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors
    Cives, M.
    Kunz, P. L.
    Morse, B.
    Coppola, D.
    Schell, M. J.
    Campos, T.
    Nguyen, P. T.
    Nandoskar, P.
    Khandelwal, V.
    Strosberg, J. R.
    ENDOCRINE-RELATED CANCER, 2015, 22 (01) : 1 - 9
  • [46] Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib
    Lara, Primo N., Jr.
    Longmate, Jeff
    Mack, Philip C.
    Kelly, Karen
    Socinski, Mark A.
    Salgia, Ravi
    Gitlitz, Barbara
    Li, Tianhong
    Koczywas, Mariana
    Reckamp, Karen L.
    Gandara, David R.
    CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4321 - 4326
  • [47] A phase I study of MK-2206, an oral potent allosteric Akt inhibitor (Akti), in patients (pts) with advanced solid tumor (ST)
    Tolcher, A. W.
    Yap, T. A.
    Fearen, I.
    Taylor, A.
    Carpenter, C.
    Brunetto, A. T.
    Beeram, M.
    Papadopoulos, K.
    Yan, L.
    de Bono, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy SWOG S1115 Study Randomized Clinical Trial
    Chung, Vincent
    McDonough, Shannon
    Philip, Philip A.
    Cardin, Dana
    Wang-Gillam, Andrea
    Hui, Laifong
    Tejani, Mohamedtaki A.
    Seery, Tara E.
    Dy, Irene A.
    Al Baghdadi, Tareq
    Hendifar, Andrew E.
    Doyle, L. Austin
    Lowy, Andrew M.
    Guthrie, Katherine A.
    Blanke, Charles D.
    Hochster, Howard S.
    JAMA ONCOLOGY, 2017, 3 (04) : 516 - 522
  • [49] Treatment patterns and clinical outcomes of patients with metastatic gastroenteropancreatic neuroendocrine tumors (mGEP-NETs).
    Jiao, Xiaolong
    Pulgar, Sonia J.
    Boyd, Marley
    Braiteh, Fadi S.
    Lowenthal, Susan Pitman
    Cox, David
    Fox, Patricia S.
    Paulson, Andrew Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Treatment Patterns and Clinical Outcomes of Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors (mGEP-NETs)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 16 - 17
12345